drugset
drugset / Trial / NCT03224117

Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

NCT03224117 ↗

Phase 2 Completed 140 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

evaluate the efficacy and safety of DWJ211 in patient with moderate or severe submental fat

Timeline

Start
2017-10-26
Primary completion
2018-06-29
Completion
2018-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule 0.5 % Subcutaneous
Subject Deoxycholic Acid Small molecule 1 % Subcutaneous
Subject Deoxycholic Acid Small molecule 2 % Subcutaneous

Indications

No indication recorded.